电疗产品市场 - 全球产业规模、份额、趋势、机会及预测（按产品、类型、应用、最终用户、地区和竞争格局划分，2021-2031年）

全球电疗产品市场预计将从 2025 年的 246.1 亿美元成长到 2031 年的 365.4 亿美元，复合年增长率为 6.81%。

电疗产品是指旨在透过向神经迴路提供靶向电刺激来治疗急性慢性疾病的生物电子医疗设备。该市场的主要驱动力是神经系统疾病和心血管疾病发病率的上升，以及人口老化导致人们倾向于选择微创、非药物疗法。日益加重的疾病负担凸显了先进生物电子介入的重要性。例如，根据美国心臟协会 (AHA) 2024 年的报告，美国约有 1.28 亿成年人患有某种形式的心血管疾病。

阻碍市场成长的主要障碍之一是医疗设备核准的严格监管环境。严格的临床试验要求和漫长的审批流程往往导致高昂的研发成本和商业化进程的延误。此外，器械植入和长期管理的高昂费用也会限制病患的就医和使用率，尤其是在医疗报销有限的地区。

市场驱动因素

全球慢性病和神经系统疾病盛行率的不断上升是推动先进生物电子疗法需求的主要因素，进而促进了全球电疗市场的发展。随着癫痫和慢性疼痛等疾病负担的日益加重，医疗系统正优先考虑采用非药物疗法来克服传统药物疗法的限制。根据世界神经病学会联盟于2025年10月发布的报告《世界卫生组织报告：神经系统疾病影响全球超过三分之一的人口》，目前全球有超过30亿人患有神经系统疾病。不断扩大的患者群体正直接影响市场趋势。例如，美敦力公司在其2025年8月发布的「2026财年第一季财务业绩」中报告称，其神经调控业务的收入增长了10.2%，表明这些技术正在迅速被临床应用。

生物电子领域策略性投资和研发资金的激增，正进一步推动该领域的发展，协助创新治疗方法从临床试验走向商业化。投资者积极为开发用于治疗自体免疫疾病和发炎性疾病的植入式医疗器材的公司提供资金支持，帮助它们顺利通过监管审批流程。 SetPoint Medical 就是一个显着的例子。该公司于 2025 年 8 月发布题为「SetPoint Medical 宣布获得 1.4 亿美元私募资金筹措」的新闻稿，宣布已获得 1.4 亿美元的资金筹措，用于推进其神经免疫调节平台的商业化进程。如此大规模的资金筹措验证了生物电子技术的治疗潜力，并确保企业拥有足够的资源来扩大生产规模并扩大全球市场。

市场挑战

生物电子医疗设备核准的严格监管环境仍是限制全球电疗市场成长的一大挑战。这些复杂技术的研发需要遵循严格的安全性和有效性标准，这需要进行广泛且高成本的临床试验。卫生监管机构规定的漫长审批流程显着延长了产品上市时间，并增加了研发成本。这种繁琐的审批环境为新兴企业设定了很高的进入门槛，抑制了对创新技术的投资，并有效地减缓了新治疗方法上市的速度。

因此，这种监管瓶颈严重限制了该行业利用日益增长的神经系统疾病和慢性病治疗需求的能力。当前医疗需求与已通过核准的医疗器材供应之间的脱节，阻碍了患者获得治疗和市场渗透。例如，根据世界神经病学联合会 (WFN) 2024 年的报告，全球将有超过 30 亿人患有神经系统疾病。儘管市场潜力巨大，但缓慢的监管核准阻碍了製造商及时惠及这些患者，直接限制了收入潜力和全球市场的整体扩张。

市场趋势

非侵入式穿戴式电疗解决方案的普及正在重塑市场格局，将医疗保健从临床环境转移到家庭管理。这一趋势的驱动力在于，患者对以患者为中心的治疗方法的需求日益增长，这些疗法避免了传统植入式设备带来的手术风险和恢復期。利用经皮刺激技术，製造商正在开发穿戴式系统，有效缓解自发性震颤和偏头痛等疾病，从而提高患者的就医便利性和治疗依从性。这种向便捷生物电子技术的转变正在吸引大量资金，以扩大其商业性应用。例如，Cala Health 在 2024 年 12 月的新闻稿「Cala Health 完成 5,000 万美元超额认购资金筹措」中宣布，已获得 5,000 万美元融资，用于加速其可穿戴式 TAPS 疗法的商业性发展，这印证了市场对这种非侵入式疗法的坚定信心。

同时，融合人工智慧的个人化神经调控技术正在拓展生物电子系统的功能，使其超越固定输出刺激的限制。现代设备越来越多地利用机器学习演算法和神经回馈的即时分析，透过根据患者生理状态的变化自动调整刺激参数，实现封闭回路型治疗。这项技术进步确保了能够精准地提供符合个别神经特征的电脉衝，从而提高疗效并减少副作用。这些智慧系统的商业性可行性已在主要产业参与者的业绩中得到充分体现。例如，Nevro公司在其2024年11月发布的「2024年第三季财报」中重申了其年度营收预期，约为4亿至4.05亿美元，这主要得益于其人工智慧驱动的HFX AdaptivAI平台的市场推广。

目录

第一章概述

第二章调查方法

第三章执行摘要

第四章：客户评价

第五章 全球电疗产品市场展望

• 市场规模及预测
  • 按金额
• 市占率及预测
  • 副产品（心臟节律器/植入式心臟整流去颤器、人工电子耳、调变器、视网膜植入）
  • 按类型（植入式电疗设备、非侵入式电疗设备）
  • 依应用领域（心律不整、忧郁症、巴金森氏症、震颤、癫痫、感音性听障等）
  • 按最终使用者（医院、门诊手术中心、诊断中心、其他）
  • 按地区
  • 按公司（2025 年）
• 市场地图

第六章：北美电疗产品市场展望

• 市场规模及预测
• 市占率及预测
• 北美洲：国家分析
  • 我们
  • 加拿大
  • 墨西哥

7. 欧洲电疗产品市场展望

• 市场规模及预测
• 市占率及预测
• 欧洲：国家分析
  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙

第八章：亚太地区电疗产品市场展望

• 市场规模及预测
• 市占率及预测
• 亚太地区：国家分析
  • 中国
  • 印度
  • 日本
  • 韩国
  • 澳洲

第九章：中东和非洲电疗产品市场展望

• 市场规模及预测
• 市占率及预测
• 中东和非洲：国家分析
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 南非

第十章：南美洲电疗产品市场展望

• 市场规模及预测
• 市占率及预测
• 南美洲：国家分析
  • 巴西
  • 哥伦比亚
  • 阿根廷

第十一章 市场动态

• 司机
• 任务

第十二章 市场趋势与发展

• 併购
• 产品发布
• 最新进展

第十三章 全球电疗产品市场：SWOT分析

第十四章：波特五力分析

• 产业竞争
• 新进入者的可能性
• 供应商电力
• 顾客权力
• 替代品的威胁

第十五章 竞争格局

• Medtronic
• Boston Scientific
• Abbott
• LivaNova
• NeuroPace
• Cochlear
• Saluda Medical
• Stimwave
• Nevro
• Synapse Biomedical

第十六章 策略建议

第十七章：关于研究公司及免责声明

The Global Electroceuticals Market is projected to expand from USD 24.61 Billion in 2025 to USD 36.54 Billion by 2031, reflecting a CAGR of 6.81%. Electroceuticals are defined as bioelectronic medical devices designed to deliver targeted electrical stimulation to neural circuits for the management of both chronic and acute diseases. The market is largely supported by the rising incidence of neurological and cardiovascular disorders, along with an aging population that increasingly favors minimally invasive and non-pharmacological treatments. This escalating disease burden highlights the critical need for advanced bioelectronic interventions; for example, the American Heart Association reported in 2024 that approximately 128 million adults in the United States were affected by some form of cardiovascular disease.

One significant obstacle hindering market growth is the strict regulatory environment governing the approval of these medical devices. The demanding requirements for clinical trials and protracted authorization procedures often lead to substantial development costs and delays in commercialization. Additionally, the high expenses associated with device implantation and long-term management can restrict patient access and adoption rates, particularly in regions with limited healthcare reimbursement frameworks.

Market Driver

The escalating global prevalence of chronic and neurological disorders serves as a primary catalyst for the Global Electroceuticals Market, driving the demand for advanced bioelectronic interventions. As the burden of conditions such as epilepsy and chronic pain grows, healthcare systems are prioritizing non-pharmacological therapies to overcome the limitations of traditional medication. According to a report highlighted by the World Federation of Neurology in October 2025, titled 'WHO Report Finds Neurological Conditions Now Affect Over One-Third of the World's Population,' neurological conditions now affect over 3 billion individuals globally. This expanding patient population has directly influenced market performance; for instance, Medtronic reported a 10.2% revenue increase in its Neuromodulation business in its 'First Quarter Fiscal 2026 Financial Results' in August 2025, underscoring the rapid clinical adoption of these technologies.

A surge in strategic investments and R&D funding for bioelectric medicine is further propelling the sector by supporting the transition of novel therapies from clinical trials to commercial availability. Investors are actively providing capital to companies developing implantable devices for autoimmune and inflammatory diseases to help them navigate regulatory pathways. A notable example occurred in August 2025, when SetPoint Medical announced in the press release 'SetPoint Medical Raises $140 Million in Private Financing' that it had secured $140 million to advance the commercial rollout of its neuroimmune modulation platform. Such significant funding validates the therapeutic potential of bioelectronics and ensures that companies have the resources to scale manufacturing and expand global market access.

Market Challenge

The stringent regulatory landscape governing the approval of bioelectronic medical devices remains a primary challenge impeding the growth of the Global Electroceuticals Market. Developing these complex technologies demands adherence to rigorous safety and efficacy standards, which necessitates extensive and costly clinical trials. The lengthy authorization processes mandated by health authorities significantly prolong commercialization timelines and increase development expenses. This burdensome environment creates high barriers to entry for emerging companies and discourages investment in novel innovations, effectively slowing the rate at which new therapies can be introduced to the market.

Consequently, this regulatory bottleneck severely restricts the industry's ability to capitalize on the rising demand for neurological and chronic disease treatments. The disparity between urgent medical needs and the availability of approved devices limits patient access and market penetration. For instance, the World Federation of Neurology reported in 2024 that over 3 billion individuals worldwide are living with a neurological condition. Despite this massive addressable market, the slow pace of regulatory clearance prevents manufacturers from reaching these patients in a timely manner, thereby directly constraining potential revenue and the overall expansion of the global market.

Market Trends

The proliferation of non-invasive and wearable electroceutical solutions is reshaping the market by moving care from clinical settings to home-based management. This trend is driven by a growing demand for patient-centric therapies that avoid the surgical risks and recovery times associated with traditional implantable devices. Utilizing transcutaneous stimulation technologies, manufacturers are developing wearable systems that provide effective symptom relief for conditions such as essential tremor and migraine, thereby improving patient access and adherence. This shift toward accessible bioelectronics is attracting significant capital to scale commercial availability; for instance, Cala Health announced in December 2024 in the press release 'Cala Health Closes Oversubscribed $50 Million Financing' that it secured $50 million to accelerate the commercial growth of its wearable TAPS therapy, validating strong market confidence in non-invasive modalities.

Simultaneously, the integration of artificial intelligence for personalized neuromodulation is advancing the capabilities of bioelectronic systems beyond fixed-output stimulation. Modern devices increasingly employ machine learning algorithms to analyze neural feedback in real-time, enabling closed-loop therapies that automatically adjust stimulation parameters to the patient's changing physiological state. This technological evolution improves therapeutic efficacy and reduces side effects by ensuring electrical pulses are delivered with precision tailored to individual neural signatures. The commercial viability of these intelligent systems is evident in the performance of key industry players; for example, Nevro Corp. reaffirmed full-year revenue guidance of approximately $400 million to $405 million in its 'Third-Quarter 2024 Financial Results' in November 2024, a projection underpinned by the limited market launch of its AI-driven HFX AdaptivAI platform.

Key Market Players

• Medtronic
• Boston Scientific
• Abbott
• LivaNova
• NeuroPace
• Cochlear
• Saluda Medical
• Stimwave
• Nevro
• Synapse Biomedical

Report Scope

In this report, the Global Electroceuticals Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Electroceuticals Market, By Product

• Cardiac Pacemakers & Implantable Cardioverter Defibrillators
• Cochlear Implants
• Neuromodulators
• Retinal Implants

Electroceuticals Market, By Type

• Implantable Electroceutical Devices
• Non-Invasive Electroceutical Devices

Electroceuticals Market, By Application

• Arrhythmia
• Depression
• Parkinson Disease
• Tremor
• Epilepsy
• Sensorineural Hearing Loss
• Others

Electroceuticals Market, By End User

• Hospitals
• Ambulatory Surgical Centers
• Diagnostics Centers
• Others

Electroceuticals Market, By Region

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Electroceuticals Market.

Available Customizations:

Global Electroceuticals Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Electroceuticals Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Product (Cardiac Pacemakers & Implantable Cardioverter Defibrillators, Cochlear Implants, Neuromodulators, Retinal Implants)
  • 5.2.2. By Type (Implantable Electroceutical Devices, Non-Invasive Electroceutical Devices)
  • 5.2.3. By Application (Arrhythmia, Depression, Parkinson Disease, Tremor, Epilepsy, Sensorineural Hearing Loss, Others)
  • 5.2.4. By End User (Hospitals, Ambulatory Surgical Centers, Diagnostics Centers, Others)
  • 5.2.5. By Region
  • 5.2.6. By Company (2025)
• 5.3. Market Map

6. North America Electroceuticals Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Product
  • 6.2.2. By Type
  • 6.2.3. By Application
  • 6.2.4. By End User
  • 6.2.5. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Electroceuticals Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Product
      • 6.3.1.2.2. By Type
      • 6.3.1.2.3. By Application
      • 6.3.1.2.4. By End User
  • 6.3.2. Canada Electroceuticals Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Product
      • 6.3.2.2.2. By Type
      • 6.3.2.2.3. By Application
      • 6.3.2.2.4. By End User
  • 6.3.3. Mexico Electroceuticals Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Product
      • 6.3.3.2.2. By Type
      • 6.3.3.2.3. By Application
      • 6.3.3.2.4. By End User

7. Europe Electroceuticals Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Product
  • 7.2.2. By Type
  • 7.2.3. By Application
  • 7.2.4. By End User
  • 7.2.5. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Electroceuticals Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Product
      • 7.3.1.2.2. By Type
      • 7.3.1.2.3. By Application
      • 7.3.1.2.4. By End User
  • 7.3.2. France Electroceuticals Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Product
      • 7.3.2.2.2. By Type
      • 7.3.2.2.3. By Application
      • 7.3.2.2.4. By End User
  • 7.3.3. United Kingdom Electroceuticals Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Product
      • 7.3.3.2.2. By Type
      • 7.3.3.2.3. By Application
      • 7.3.3.2.4. By End User
  • 7.3.4. Italy Electroceuticals Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Product
      • 7.3.4.2.2. By Type
      • 7.3.4.2.3. By Application
      • 7.3.4.2.4. By End User
  • 7.3.5. Spain Electroceuticals Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Product
      • 7.3.5.2.2. By Type
      • 7.3.5.2.3. By Application
      • 7.3.5.2.4. By End User

8. Asia Pacific Electroceuticals Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Product
  • 8.2.2. By Type
  • 8.2.3. By Application
  • 8.2.4. By End User
  • 8.2.5. By Country
• 8.3. Asia Pacific: Country Analysis
  • 8.3.1. China Electroceuticals Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Product
      • 8.3.1.2.2. By Type
      • 8.3.1.2.3. By Application
      • 8.3.1.2.4. By End User
  • 8.3.2. India Electroceuticals Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Product
      • 8.3.2.2.2. By Type
      • 8.3.2.2.3. By Application
      • 8.3.2.2.4. By End User
  • 8.3.3. Japan Electroceuticals Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Product
      • 8.3.3.2.2. By Type
      • 8.3.3.2.3. By Application
      • 8.3.3.2.4. By End User
  • 8.3.4. South Korea Electroceuticals Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Product
      • 8.3.4.2.2. By Type
      • 8.3.4.2.3. By Application
      • 8.3.4.2.4. By End User
  • 8.3.5. Australia Electroceuticals Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Product
      • 8.3.5.2.2. By Type
      • 8.3.5.2.3. By Application
      • 8.3.5.2.4. By End User

9. Middle East & Africa Electroceuticals Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Product
  • 9.2.2. By Type
  • 9.2.3. By Application
  • 9.2.4. By End User
  • 9.2.5. By Country
• 9.3. Middle East & Africa: Country Analysis
  • 9.3.1. Saudi Arabia Electroceuticals Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Product
      • 9.3.1.2.2. By Type
      • 9.3.1.2.3. By Application
      • 9.3.1.2.4. By End User
  • 9.3.2. UAE Electroceuticals Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Product
      • 9.3.2.2.2. By Type
      • 9.3.2.2.3. By Application
      • 9.3.2.2.4. By End User
  • 9.3.3. South Africa Electroceuticals Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Product
      • 9.3.3.2.2. By Type
      • 9.3.3.2.3. By Application
      • 9.3.3.2.4. By End User

10. South America Electroceuticals Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Product
  • 10.2.2. By Type
  • 10.2.3. By Application
  • 10.2.4. By End User
  • 10.2.5. By Country
• 10.3. South America: Country Analysis
  • 10.3.1. Brazil Electroceuticals Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Product
      • 10.3.1.2.2. By Type
      • 10.3.1.2.3. By Application
      • 10.3.1.2.4. By End User
  • 10.3.2. Colombia Electroceuticals Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Product
      • 10.3.2.2.2. By Type
      • 10.3.2.2.3. By Application
      • 10.3.2.2.4. By End User
  • 10.3.3. Argentina Electroceuticals Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Product
      • 10.3.3.2.2. By Type
      • 10.3.3.2.3. By Application
      • 10.3.3.2.4. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition (If Any)
• 12.2. Product Launches (If Any)
• 12.3. Recent Developments

13. Global Electroceuticals Market: SWOT Analysis

14. Porter's Five Forces Analysis

• 14.1. Competition in the Industry
• 14.2. Potential of New Entrants
• 14.3. Power of Suppliers
• 14.4. Power of Customers
• 14.5. Threat of Substitute Products

15. Competitive Landscape

• 15.1. Medtronic
  • 15.1.1. Business Overview
  • 15.1.2. Products & Services
  • 15.1.3. Recent Developments
  • 15.1.4. Key Personnel
  • 15.1.5. SWOT Analysis
• 15.2. Boston Scientific
• 15.3. Abbott
• 15.4. LivaNova
• 15.5. NeuroPace
• 15.6. Cochlear
• 15.7. Saluda Medical
• 15.8. Stimwave
• 15.9. Nevro
• 15.10. Synapse Biomedical

16. Strategic Recommendations

17. About Us & Disclaimer